Blue Jet Healthcare Limited (BLUEJET.BO)
- Previous Close
837.55 - Open
858.50 - Bid 823.45 x --
- Ask 823.90 x --
- Day's Range
814.85 - 858.50 - 52 Week Range
346.70 - 968.75 - Volume
28,658 - Avg. Volume
41,479 - Market Cap (intraday)
142.84B - Beta (5Y Monthly) --
- PE Ratio (TTM)
60.68 - EPS (TTM)
13.57 - Earnings Date Aug 6, 2025 - Aug 7, 2025
- Forward Dividend & Yield 1.00 (0.12%)
- Ex-Dividend Date Sep 18, 2024
- 1y Target Est
907.50
Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norway, France, the United States, Italy, Sweden, Spain, and internationally. Blue Jet Healthcare Limited was incorporated in 1968 and is headquartered in Thane, India.
www.bluejethealthcare.comRecent News: BLUEJET.BO
View MorePerformance Overview: BLUEJET.BO
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BLUEJET.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BLUEJET.BO
View MoreValuation Measures
Market Cap
145.29B
Enterprise Value
141.55B
Trailing P/E
61.86
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
16.65
Price/Book (mrq)
15.72
Enterprise Value/Revenue
16.23
Enterprise Value/EBITDA
42.42
Financial Highlights
Profitability and Income Statement
Profit Margin
28.36%
Return on Assets (ttm)
20.50%
Return on Equity (ttm)
30.86%
Revenue (ttm)
10.76B
Net Income Avi to Common (ttm)
3.05B
Diluted EPS (ttm)
13.57
Balance Sheet and Cash Flow
Total Cash (mrq)
3.06B
Total Debt/Equity (mrq)
1.76%
Levered Free Cash Flow (ttm)
-628.79M